老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Evaxion Biotech A/S

3.78
-0.1600-4.06%
盘后：3.780.00000.00%16:10 EDT
成交量：3,804.00
成交额：1.43万
市值：3,138.42万
市盈率：-3.14
高：3.87
开：3.71
低：3.61
收：3.94
52周最高：12.15
52周最低：1.20
股本：830.27万
流通股本：553.19万
量比：0.15
换手率：0.07%
股息：- -
股息率：- -
每股收益(TTM):-1.2027
每股收益(LYR):-1.2027
净资产收益率：-100.18%
总资产收益率：-28.23%
市净率：1.84
市盈率(LYR):-3.14

数据加载中...

总览公司新闻资讯公告
2024/01/30

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/01/23

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/12

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2023/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/08/24

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/22

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/07/07

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/06/01

SEC问询函

CORRESP [Cover] - Correspondence
2022/03/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/10/29

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/29

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/26

招股说明书

F-1 - Registration statement for certain foreign private issuers
2021/05/13

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/04/07

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/06

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/06

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/02

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/02

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/01

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/02/01

SEC问询函

CORRESP [Cover] - Correspondence
更多